Cargando…

Optimized Treatment and Heart Rate Reduction in Chronic Heart Failure

BACKGROUND: Heart failure (HF) is a syndrome that leads to poor outcome in advanced forms. The neurohormonal blockade modifies this natural history; however, it is often suboptimal. OBJECTIVE: The aim of this study is to assess at what percentage cardiologists used to treating HF can prescribe targe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moreno, Irineu Blanco, Del Carlo, Carlos Henrique, Pereira-Barretto, Antônio Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia 2013
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081168/ https://www.ncbi.nlm.nih.gov/pubmed/24100693 http://dx.doi.org/10.5935/abc.20130201

Ejemplares similares

Optimization of Heart Failure Treatment by Heart Rate Reduction
por: Böhm, Michael, et al.
Publicado: (2019)

Temporal Variation in the Prognosis and Treatment of Advanced Heart Failure - Before and After 2000
por: Del Carlo, Carlos Henrique, et al.
Publicado: (2014)

Infection in Patients with Decompensated Heart Failure: In-Hospital Mortality and Outcome
por: Cardoso, Juliano Novaes, et al.
Publicado: (2018)

Sex Differences in Prognosis of Heart Failure Due to Ischemic and Nonischemic Cardiomyopathy
por: Mansur, Antonio de Padua, et al.
Publicado: (2023)

Addressing Major Unmet Needs in Patients with Systolic Heart Failure: The Role of Ivabradine
por: Pereira-Barretto, Antonio Carlos
Publicado: (2016)

Benefit of Heart Rate Reduction in Heart Failure
por: Hasenfuss, Gerd
Publicado: (2010)

Heart Rate Reduction and Outcomes in Heart Failure Outpatients
por: Memenga, Felix, et al.
Publicado: (2023)

Testosterone Deficiency Increases Hospital Readmission and Mortality Rates in Male Patients with Heart Failure
por: dos Santos, Marcelo Rodrigues, et al.
Publicado: (2015)

Sex Differences in Heart Failure Mortality with Preserved, Mildly Reduced and Reduced Ejection Fraction: A Retrospective, Single-Center, Large-Cohort Study
por: Mansur, Antonio de Padua, et al.
Publicado: (2022)

Optimal Usage of Sacubitril/Valsartan for the Treatment of Heart Failure: The Importance of Optimizing Heart Failure Care in Canada
por: Huitema, Ashlay A., et al.
Publicado: (2020)

Reverse Cardiac Remodeling: A Marker of Better Prognosis in Heart Failure
por: Reis, José Rosino de Araújo Rocha, et al.
Publicado: (2015)

Predictors of low cardiac output in decompensated severe heart failure
por: Ochiai, Marcelo Eidi, et al.
Publicado: (2011)

Treatment optimization of beta-blockers in chronic heart failure therapy
por: Niriayo, Yirga Legesse, et al.
Publicado: (2020)

Is heart rate reduction more important than target dose in chronic heart failure therapy with a beta-blocker?
por: Guo, Yong-Fang, et al.
Publicado: (2011)

HEART FAILURE HOSPITALIZATION RATE REDUCTION DURING COVID-19 PANDEMIC
por: D’Amato, Andrea, et al.
Publicado: (2021)

Perceived risk profile and treatment optimization in heart failure: an analysis from BIOlogy Study to TAilored Treatment in chronic heart failure
por: Kobayashi, Masatake, et al.
Publicado: (2021)

Adherence to optimal heart rate control in heart failure with reduced ejection fraction: insight from a survey of heart rate in heart failure in Sweden (HR-HF study)
por: Fu, M., et al.
Publicado: (2017)

Opportunities for Care Optimization and Hospitalization Reduction for Older Persons With Heart Failure
por: Azad , Nahid
Publicado: (2019)

Heart Rate Variability and Chagas Heart Disease
por: Almeida-Santos, Marcos Antonio, et al.
Publicado: (2015)

Shielding the Heart: Preload Reduction Therapies in Heart Failure
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2023)

Prognostic significance of heart rate turbulence parameters in patients with chronic heart failure
por: Yin, De-Chun, et al.
Publicado: (2014)

Reverse re-modelling chronic heart failure by reinstating heart rate variability
por: Shanks, J., et al.
Publicado: (2022)

Android to gynoid fat ratio and its association with functional capacity in male patients with heart failure
por: Dos Santos, Marcelo Rodrigues, et al.
Publicado: (2020)

Ambulatory heart rate range predicts mode-specific mortality and hospitalisation in chronic heart failure
por: Cubbon, Richard M, et al.
Publicado: (2016)

Nebivolol in the treatment of chronic heart failure
por: Veverka, Angie, et al.
Publicado: (2007)

Bisoprolol in the treatment of chronic heart failure
por: de Groote, Pascal, et al.
Publicado: (2007)

Reduction in heart failure hospitalization rate during coronavirus disease 19 pandemic outbreak
por: Severino, Paolo, et al.
Publicado: (2020)

Mortality by Heart Failure and Ischemic Heart Disease in Brazil from 1996 to 2011
por: Gaui, Eduardo Nagib, et al.
Publicado: (2014)

Transient heart rate reduction improves acute decompensated heart failure‐induced left ventricular and coronary dysfunction
por: Peschanski, Nicolas, et al.
Publicado: (2021)

Heart rate reduction as a marker to optimize carvedilol treatment and enhance myocardial recovery in pediatric dilated cardiomyopathy
por: Adorisio, Rachele, et al.
Publicado: (2022)

Levosimendan treatment for acutely decompensated heart failure is as effective for Chagas disease patients as for patients with other etiologies
por: Pereira-Barretto, AC, et al.
Publicado: (2003)

Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program
por: Preiss, David, et al.
Publicado: (2009)

Heart rate and blood pressure monitoring in heart failure
por: Ponikowski, Piotr, et al.
Publicado: (2019)

Intestinal permeability evaluation in patients with chronic Chagas heart failure
por: Rodrigues, Angela Braga, et al.
Publicado: (2023)

Effect of Carvedilol on Reduction in Heart Rate in Patients With Chronic Atrial Fibrillation
por: Kodani, Eitaro, et al.
Publicado: (2013)

Heart rate response and functional capacity in patients with chronic heart failure with preserved ejection fraction
por: Domínguez, Eloy, et al.
Publicado: (2018)

Prognostic value of daytime heart rate, blood pressure, their products and quotients in chronic heart failure
por: Kowalczys, Anna, et al.
Publicado: (2019)

Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
por: Grassi, Guido, et al.
Publicado: (2022)

Left Univentricular Pacing by Rate-Adaptive Atrioventricular Delay in Treatment of Chronic Heart Failure
por: Zhao, Lulu, et al.
Publicado: (2017)

Diabetes and treatment of chronic heart failure in a large real‐world heart failure population
por: Radhoe, Sumant P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9i1k5msl9lafu90hvve3o08agm